Top Markets
#1 Siren Siren +44.16%
#2 Seeker Seeker +32.30%
#3 Full Moon Full Moon +19.18%
#4 Zora Zora +17.31%
#5 Wrapped NXM Wrapped NXM +12.17%
#6 VVS Finance VVS Finance +10.82%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.49%
#8 Cryptopia Cryptopia +9.12%
#9 Axelar Axelar +8.99%
#10 0G 0G +8.98%
Coin of the day
Siren Siren
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Jinling Pharmaceutical Company Limited Jinling Pharmaceutical Company Limited

Jinling Pharmaceutical Company Limited

000919
Rang in Aktien #12123
Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in... Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in the manufacture and distribution of a diverse range of pharmaceutical products. Its key offerings include the Mailuoning injection, prescribed for the management of numerous vascular and thrombotic conditions such as thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and its sequelae, multiple forms of arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, and thrombophlebitis. The company also provides ferrous succinate tablets for the prevention and treatment of iron deficiency anemia, alongside lentinan injection used in the therapy of malignant tumors. Furthermore, Jinling Pharmaceutical offers medical health care services. The firm's operations are primarily based in Nanjing, China.
Aktienkurs
$0.96947389
Marktkapitalisierung
$602.94M
Veränderung (1 Tag)
-2.34%
Veränderung (1 Jahr)
-2.77%
Land
CN
Handel Jinling Pharmaceutical Company Limited (000919)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Jinling Pharmaceutical Company Limited (000919)
Dividendenrendite (TTM) von Jinling Pharmaceutical Company Limited (Aktienkürzel: 000919) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Jinling Pharmaceutical Company Limited (000919) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.58%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.00%
US